Cargando…
Nivolumab therapy for metastatic collecting duct carcinoma after nephrectomy: A case report
RATIONALE: Collecting duct carcinoma (CDC) is a rare type of nonclear renal cell carcinoma, often presenting at an advanced stage of the disease, and standard treatment guidelines have not been established. PATIENT CONCERNS: A 73-year-old man was admitted to our hospital with complaints of fever and...
Autores principales: | Yasuoka, Shotaro, Hamasaki, Tsutomu, Kuribayashi, Eigo, Nagasawa, Masato, Kawaguchi, Takanori, Nagashima, Yoji, Kondo, Yukihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250451/ https://www.ncbi.nlm.nih.gov/pubmed/30407350 http://dx.doi.org/10.1097/MD.0000000000013173 |
Ejemplares similares
-
Nivolumab and Ipilimumab Combination Immunotherapy for Patients with Metastatic Collecting Duct Carcinoma
por: Danno, Tetsuya, et al.
Publicado: (2021) -
Inferior vena cava tumor thrombus after partial nephrectomy for renal cell carcinoma
por: Akatsuka, Jun, et al.
Publicado: (2014) -
Response to nivolumab in metastatic collecting duct carcinoma expressing PD-L1: A case report
por: Mizutani, Kosuke, et al.
Publicado: (2017) -
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients
por: Buti, Sebastiano, et al.
Publicado: (2022) -
Successful Treatment with Nivolumab in a Patient with Metastatic Salivary Duct Carcinoma
por: Sato, Tsuyoshi, et al.
Publicado: (2021)